Giles Palmer

Giles Palmer is a senior clinical embryologist with over 35 years of experience in staff training and laboratory management. He has served as a business and quality manager, overseeing regulatory compliance, clinic operations, bidding for service contracts, and designing laboratories. Additionally, he has extensive experience in conducting clinic audits, inspections and troubleshooting.

Giles is the Executive Director of the International IVF Initiative (I3), a non-profit global educational project supporting assisted reproduction technology professionals through insightful webinars and is an honorary lecturer at Bristol University. He has a keen interest in teaching and introducing innovations to the fertility sector serving as the Director of Global Communications for IVF 2.0 Ltd. and an assessor for the ESHRE accreditation of training centres in clinical embryology.

Giles is a well-known reproductive scientist and frequent invited congress speaker. He began his career after graduating in Genetics from Leeds University, UK and working as a research officer at London’s esteemed Hammersmith Hospital IVF unit with pioneers Professors Lord Winston and Alan Handyside. He then moved to Greece and worked as a laboratory manager and clinic director in IVF clinics in Athens while consulting in Iceland, Nigeria, Albania, Bulgaria, and Romania. His research collaboration with St. Sophia’s Children’s Hospital (Athens University) resulted in Greece’s first births following embryo-biopsy and pre-implantation genetic diagnosis and the first PGT cycles screening for Beta Thalassemia.

Giles has published in leading scientific journals on pre-implantation genetic testing, embryo morpho-kinetics, quality management, staff wellbeing, artificial intelligence, and the latest laboratory technologies. He is a certified HCPC clinical scientist in the UK and has been accredited with Senior Embryologist Status by ESHRE.

Recently, Giles has become a consultant for IVF clinics and is a product developer in various areas within the assisted reproductive technologies industry